Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any non-syndromic X-linked intellectual disability in which the cause of the disease is a mutation in the KLHL15 gene.
Features include always present findings: Wide mouth, Lateral ventricle dilatation, Micropenis, and Absent speech and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 5 | Absent speech, Delayed speech and language development, Seizure |
KLHL15 encodes kelch like family member 15 (604 aa). Substrate-specific adapter for CUL3 E3 ubiquitin-protein ligase complex. Highest expression in Testis (22.2 TPM) and Cells EBV-transformed lymphocytes (10.1 TPM).
Intellectual disability, X-linked 103 is associated with mutations in the KLHL15 gene on chromosome X.
KLHL15 is classified as a druggable target (Druggable Genome category) with score 0.0.
Genetic testing for KLHL15 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for intellectual disability, X-linked 103 has been reported in the published literature.
Phenotype severity distribution: 14 always present features.
No clinical trials have been registered for intellectual disability, X-linked 103.
13 publications have been identified in PubMed for intellectual disability, X-linked 103. Research spans Review / Meta-Analysis (23%), Case Report / Case Series (23%), and Other (15%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 3 | 23% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 3:01 PM UTC
Online Mendelian Inheritance in Man
1 |
Coarse facial features |
3 |
23% |
Other research | 2 | 15% |
Disease patterns and progression | 2 | 15% |
Testing and diagnosis research | 1 | 8% |
Laboratory research | 1 | 8% |
New treatment approaches | 1 | 8% |
Pan X (2026). [PMID: 41764152](https://pubmed.ncbi.nlm.nih.gov/41764152/). *J Mol Med (Berl)*. [Basic Science / Preclinical]
Ślusarczyk K (2026). [PMID: 41581294](https://pubmed.ncbi.nlm.nih.gov/41581294/). *Mol Genet Metab*. [Case Report / Case Series]
Good K (2025). [PMID: 39761540](https://pubmed.ncbi.nlm.nih.gov/39761540/). *Biochem Cell Biol*. [Review / Meta-Analysis]
Au CWM (2025). [PMID: 40468528](https://pubmed.ncbi.nlm.nih.gov/40468528/). *Hong Kong Med J*. [Epidemiology / Natural History]
You Y (2025). [PMID: 41451493](https://pubmed.ncbi.nlm.nih.gov/41451493/). *Zhonghua Yi Xue Yi Chuan Xue Za Zhi*. [Review / Meta-Analysis]
Klusek J (2025). [PMID: 40418066](https://pubmed.ncbi.nlm.nih.gov/40418066/). *Am J Med Genet B Neuropsychiatr Genet*. [Epidemiology / Natural History]
Fortin O (2024). [PMID: 39102617](https://pubmed.ncbi.nlm.nih.gov/39102617/). *Neurology*. [Other]
Agusti I (2024). [PMID: 38760837](https://pubmed.ncbi.nlm.nih.gov/38760837/). *J Ovarian Res*. [Other]
Sloper E (2024). [PMID: 39707431](https://pubmed.ncbi.nlm.nih.gov/39707431/). *Orphanet J Rare Dis*. [Review / Meta-Analysis]
Pierpont EI (2024). [PMID: 39151102](https://pubmed.ncbi.nlm.nih.gov/39151102/). *Neurology*. [Diagnostic / Biomarker]